These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1418848

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased urinary kallikrein excretion in young borderline hypertensive patients.
    Ando K, Fujita T.
    Clin Exp Hypertens A; 1983; 5(6):903-18. PubMed ID: 6349868
    [Abstract] [Full Text] [Related]

  • 4. Plasma atrial natriuretic peptide in young normotensive subjects with a family history of hypertension and in young hypertensive patients.
    Santucci A, Ferri C, Cammarella I, Valentino S, Bellini C, Tani S, Musca A, Balsano F.
    Am J Hypertens; 1990 Oct; 3(10):782-5. PubMed ID: 2145867
    [Abstract] [Full Text] [Related]

  • 5. [Correlations between circulation levels of natriuretic atrial peptide and urinary excretion of kallikrein in young normotensive and hypertensive subjects].
    Ferri C, Cammarella I, Giarrizzo C, Bellini C, Astorre P, Di Zenzo P, Santucci A, Musca A, Balsano F.
    Ann Ital Med Int; 1991 Oct; 6(2):217-23. PubMed ID: 1836137
    [Abstract] [Full Text] [Related]

  • 6. [Atrial natriuretic factor: an epidemiological study. Preliminary results].
    Musca A, Santucci A, Ferri C, Cammarella I, Tani S, De Angelis C.
    Clin Ter; 1989 Mar 15; 128(5):313-20. PubMed ID: 2524319
    [Abstract] [Full Text] [Related]

  • 7. [Relation of atrial natriuretic peptide and endogenous digoxin-like activity in the plasma of young hypertensive patients].
    Musca A, Ferri C, Cammarella S, Tani S, Valentino S, Santucci A.
    Medicina (Firenze); 1989 Mar 15; 9(3):304-6. PubMed ID: 2533312
    [Abstract] [Full Text] [Related]

  • 8. Plasma levels of atrial natriuretic factor in mild to moderate hypertensives without signs of left ventricular hypertrophy: correlation with the known duration of hypertension.
    Dessì-Fulgheri P, Palermo R, Di Noto G, Conti V, Rinaldi L, Tesei G, Russo P, Rappelli A.
    J Hum Hypertens; 1988 Oct 15; 2(3):177-82. PubMed ID: 2976835
    [Abstract] [Full Text] [Related]

  • 9. Relationship between plasma atrial natriuretic factor and urinary kallikrein excretion in essential hypertensives.
    Dessì-Fulgheri P, Di Noto G, Palermo R, Catalini R, Russo P, Rappelli A.
    Am J Hypertens; 1991 Mar 15; 4(3 Pt 1):214-8. PubMed ID: 1828349
    [Abstract] [Full Text] [Related]

  • 10. Direct and indirect measurement of urinary kallikrein excretion in patients with essential hypertension and normotensives: relation to age and plasma renin and aldosterone levels.
    Koolen MI, Daha MR, Frölich M, Van Es LA, Van Brummelen P.
    Eur J Clin Invest; 1984 Jun 15; 14(3):171-4. PubMed ID: 6432545
    [Abstract] [Full Text] [Related]

  • 11. [Cardiac and renal sodium-modulating hormones in juvenile arterial hypertension. The physiopathological aspects and therapeutic results of a trial at the Policlinico Militare Celio in Rome].
    Musca A, Cammarella I, Ferri C, Ruggieri R, Labbadia G, Santucci A.
    Clin Ter; 1992 Dec 15; 141(12):437-46. PubMed ID: 1493665
    [Abstract] [Full Text] [Related]

  • 12. Relationship between urinary kallikrein excretion and plasma atrial natriuretic factor in essential hypertensives.
    Dessì-Fulgheri P, Di Noto G, Palermo R, Catalini R, Russo P, Rappelli A.
    J Hypertens Suppl; 1989 Dec 15; 7(6):S232-3. PubMed ID: 2534406
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma renin activity and plasma prorenin are not suppressed in hypertensives surviving to old age.
    Trenkwalder P, James GD, Laragh JH, Sealey JE.
    Am J Hypertens; 1996 Jul 15; 9(7):621-7. PubMed ID: 8806973
    [Abstract] [Full Text] [Related]

  • 15. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ, Fitz AE.
    Circulation; 1977 Nov 15; 56(5):856-9. PubMed ID: 912848
    [Abstract] [Full Text] [Related]

  • 16. Non-modulating hypertension: evidence for the involvement of kallikrein/kinin activity associated with overactivity of the renin-angiotensin system. Successful blood pressure control during long-term Na+ restriction.
    Sanchez R, Gimenez MI, Ramos F, Baglivo H, Ramirez AJ.
    J Hypertens; 1996 Nov 15; 14(11):1287-91. PubMed ID: 8934356
    [Abstract] [Full Text] [Related]

  • 17. Urinary kallikrein and salt sensitivity in essential hypertensive males.
    Ferri C, Bellini C, Carlomagno A, Perrone A, Santucci A.
    Kidney Int; 1994 Sep 15; 46(3):780-8. PubMed ID: 7996800
    [Abstract] [Full Text] [Related]

  • 18. Plasma levels of atrial natriuretic peptide in patients with borderline and essential hypertension.
    Nakamura T, Ichikawa S, Sakamaki T, Fujie M, Yagi A, Kurashina T, Murata K.
    Tohoku J Exp Med; 1988 Feb 15; 154(2):205-13. PubMed ID: 2968004
    [Abstract] [Full Text] [Related]

  • 19. The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertension.
    Iimura O, Shimamoto K, Ura N, Nakagawa M, Nishimiya T, Ando T, Yamaguchi Y, Masuda A, Ogata H, Saito S.
    Agents Actions Suppl; 1987 Feb 15; 22():247-56. PubMed ID: 3324711
    [Abstract] [Full Text] [Related]

  • 20. Greater vasodilator responsiveness to atrial natriuretic peptide in low-renin essential hypertensives.
    Bolli P, Müller FB, Linder L, Raine AE, Resink TJ, Erne P, Kiowski W, Bühler FR.
    J Hypertens Suppl; 1987 Dec 15; 5(5):S55-8. PubMed ID: 2965230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.